Medicamen OrganicsNSE:MEDIORG -4.99%32 FCF Yield % is -22.74 as of Jul. 07, 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 32/100. The stock has 11 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Medicamen Organics ranks worse than 89.77% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medicamen Organics's FCF Yield % or its related term are showing as below:
NSE:MEDIORG'
s FCF Yield % Range Over the Past 10 Years
Min: -29.82 Med: -17.6 Max: -2.37
Current: -22.74
During the past 6 years, the highest FCF Yield % of Medicamen Organics was -2.37%. The lowest was -29.82%. And the median was -17.60%.
NSE:MEDIORG's FCF Yield % is ranked worse than 89.77% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 0.67
vs NSE:MEDIORG: -22.74
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medicamen Organics FCF Yield % Related Terms
Medicamen Organics FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medicamen Organics's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicamen Organics FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medicamen Organics's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicamen Organics (NSE:MEDIORG) has a FCF Yield % of -22.74 as of Jul. 07, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medicamen Organics and its competitors. According to the industry distribution chart, Medicamen Organics ranks #904 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 89.8%.
Is Medicamen Organics' FCF Yield % too high?
Medicamen Organics' current FCF Yield % is -22.74. Based on the distribution chart, Medicamen Organics ranks #904 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicamen Organics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medicamen Organics ranks #904 out of 1007 companies for FCF Yield %. This places Medicamen Organics in the lower half of its industry. The industry median FCF Yield % is 0.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medicamen Organics and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicamen Organics's current FCF Yield % is -22.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current FCF Yield % of -22.74. The current FCF Yield % is -22.74. Medicamen Organics' overall GF Score™ is 32/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current FCF Yield % is -22.74 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
32GF Score
Get the complete analysis for NSE:MEDIORG
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDIORG has been successfully added to your 